Estimating treatment effects from single-arm trials via latent-variable modeling

Fuente: arXiv
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Haussmann, Manuel, Le, Tran Minh Son, Halla-aho, Viivi, Kurki, Samu, Leinonen, Jussi V., Koskinen, Miika, Kaski, Samuel, Lähdesmäki, Harri
Format: Preprint
Publié: 2023
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866910353811570688
author Haussmann, Manuel
Le, Tran Minh Son
Halla-aho, Viivi
Kurki, Samu
Leinonen, Jussi V.
Koskinen, Miika
Kaski, Samuel
Lähdesmäki, Harri
author_facet Haussmann, Manuel
Le, Tran Minh Son
Halla-aho, Viivi
Kurki, Samu
Leinonen, Jussi V.
Koskinen, Miika
Kaski, Samuel
Lähdesmäki, Harri
contents Randomized controlled trials (RCTs) are the accepted standard for treatment effect estimation but they can be infeasible due to ethical reasons and prohibitive costs. Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario that can also account for missing covariate observations by modeling their structured missingness patterns. Our method uses amortized variational inference to learn both group-specific and identifiable shared latent representations, which can subsequently be used for {\em (i)} patient matching if treatment outcomes are not available for the treatment group, or for {\em (ii)} direct treatment effect estimation assuming outcomes are available for both groups. We evaluate the model on a public benchmark as well as on a data set consisting of a published RCT study and real-world electronic health records. Compared to previous methods, our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.
format Preprint
id arxiv_https___arxiv_org_abs_2311_03002
institution arXiv
publishDate 2023
record_format arxiv
spellingShingle Estimating treatment effects from single-arm trials via latent-variable modeling
Haussmann, Manuel
Le, Tran Minh Son
Halla-aho, Viivi
Kurki, Samu
Leinonen, Jussi V.
Koskinen, Miika
Kaski, Samuel
Lähdesmäki, Harri
Machine Learning
Randomized controlled trials (RCTs) are the accepted standard for treatment effect estimation but they can be infeasible due to ethical reasons and prohibitive costs. Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario that can also account for missing covariate observations by modeling their structured missingness patterns. Our method uses amortized variational inference to learn both group-specific and identifiable shared latent representations, which can subsequently be used for {\em (i)} patient matching if treatment outcomes are not available for the treatment group, or for {\em (ii)} direct treatment effect estimation assuming outcomes are available for both groups. We evaluate the model on a public benchmark as well as on a data set consisting of a published RCT study and real-world electronic health records. Compared to previous methods, our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.
title Estimating treatment effects from single-arm trials via latent-variable modeling
topic Machine Learning
url https://arxiv.org/abs/2311.03002